Market Value1,526,768,979
Total Holdings52
File Date2023-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BAX / Baxter International Inc.
PTCT / PTC Therapeutics, Inc.
VERA / Vera Therapeutics, Inc.
AVTE / Aerovate Therapeutics, Inc.
ASND / Ascendis Pharma A/S
NTRA / Natera, Inc.
BOLT / Bolt Biotherapeutics, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
PDSB / PDS Biotechnology Corporation
SVRA / Savara Inc.
HZNP / Horizon Therapeutics Plc
SNDX / Syndax Pharmaceuticals, Inc.
IDXX / IDEXX Laboratories, Inc.
RXDX / Prometheus Biosciences Inc
NVCR / NovoCure Limited Call
ZNTL / Zentalis Pharmaceuticals, Inc.
KROS / Keros Therapeutics, Inc.
BSX / Boston Scientific Corporation
NXTC / NextCure, Inc.
BLUE / bluebird bio, Inc.
RVMD / Revolution Medicines, Inc.
TVTX / Travere Therapeutics, Inc.
14161H108 / Cardtronics PLC
INZY / Inozyme Pharma, Inc.
BMRN / BioMarin Pharmaceutical Inc.
DXCM / DexCom, Inc.
DYN / Dyne Therapeutics, Inc.
EXEL / Exelixis, Inc.
BIIB / Biogen Inc.
IDYA / IDEAYA Biosciences, Inc.
IMTX / Immatics N.V.
AXSM / Axsome Therapeutics, Inc.
KURA / Kura Oncology, Inc.
REPL / Replimune Group, Inc.
KDNY / Chinook Therapeutics Inc
SPY / State Street SPDR S&P 500 ETF Trust Put
RETA / Reata Pharmaceuticals Inc - Class A
CTIC / CTI BioPharma Corp
SRPT / Sarepta Therapeutics, Inc.
KRTX / Karuna Therapeutics, Inc.
IMGN / ImmunoGen, Inc. Call
MIRM / Mirum Pharmaceuticals, Inc.
SPRB / Spruce Biosciences, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
ALNY / Alnylam Pharmaceuticals, Inc.
VIR / Vir Biotechnology, Inc.
CYTK / Cytokinetics, Incorporated
FUSN / Fusion Pharmaceuticals Inc.
ALLK / Allakos Inc.
ISEE / IVERIC bio Inc
GRTX / Galera Therapeutics, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
SYBX / Synlogic, Inc.
IMGN / ImmunoGen, Inc.
VIR / Vir Biotechnology, Inc. Put
MRK / Merck & Co., Inc.
FGEN / FibroGen, Inc. Call
FGEN / FibroGen, Inc.
FGEN / FibroGen, Inc. Put
NCNA / NuCana plc - Depositary Receipt (Common Stock)
CLDX / Celldex Therapeutics, Inc.
INBX.V / Inhibrx, Inc.
GERN / Geron Corporation
AGEN / Agenus Inc.
LLY / Eli Lilly and Company
ISRG / Intuitive Surgical, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
MRNS / Marinus Pharmaceuticals, Inc. Call
MRNS / Marinus Pharmaceuticals, Inc.